Converging Nanochemistry: From Disease Prevention to Diagnosis and Treatment

Dear Colleagues,

Nanobioengineering converges at the frontier of basic sciences, engineering, and technology, searching for new or existing (bio)molecules and materials, understanding their interactions, and providing novel functionalities for new products and unexpected applications. Nanobioengineering offers outstanding opportunities for developing innovative platforms with potential use in prevention, diagnostics, and therapeutics within the health care field. For example, nanobioprobes and nanobioconjugates may provide alternatives for the prevention and convenient real-time diagnosis of diseases closer to the patient, and opportunities for more efficient drug delivery and targeted therapeutics compared with conventional technologies. In this context, the rational design of biological structures and/or their assembly with nanomaterials allows the on-demand development of nanobioengineered platforms with improved properties and outstanding performance, which, acting alone or in synergy, are paving the way towards a new paradigm of personalized medicine. 

This Special Issue covers recent research in the field of nanobioengineering convergence, and aims to provide a platform for studies on new (bio)molecules, hybrids and extracts with nutraceutical or therapeutical properties, novel nanobioengineered biosensors for disease diagnostics, and nanoparticles and nanobioconjugates for targeted drug delivery. This Special Issue is focused on (but not limited to) research in cancer and infectious diseases with an impact on health care. Contributions in the form of original research papers, short communications, and reviews are welcome.

Prof. Dr. Jahir Orozco Holguín
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.